Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 2 |
TSMC
TSM
|
+$429M |
| 3 |
Microsoft
MSFT
|
+$404M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$319M |
| 5 |
NVIDIA
NVDA
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$508M |
| 2 |
Apple
AAPL
|
+$204M |
| 3 |
SEE
Sealed Air
SEE
|
+$179M |
| 4 |
HOLX
Hologic
HOLX
|
+$166M |
| 5 |
Advanced Micro Devices
AMD
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.15% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.34% |
| 4 | Consumer Discretionary | 2.9% |
| 5 | Healthcare | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Yeti Holdings
YETI
$3.19B
| $1.31M | ﹤0.01% |
+26,414
| New | +$1.15M |
|
2202
CALL
Liquidia Corp
LQDA
$6.14B
| $1.31M | ﹤0.01% |
+16,400
| New | +$879K |
|
2203
QCR Holdings
QCRH
$1.66B
| $1.3M | ﹤0.01% |
13,385
+1,444
| +12% | +$133K |
|
2204
CALL
Zevra Therapeutics
ZVRA
$705M
| $1.3M | ﹤0.01% |
90,800
-41,900
| -32% | -$466K |
|
2205
CALL
Campbell Soup
CPB
$7.14B
| $1.3M | ﹤0.01% |
58,300
-78,700
| -57% | -$1.66M |
|
2206
Honda
HMC
$43.3B
| $1.3M | ﹤0.01% |
47,839
-372,842
| -89% | -$9.48M |
|
2207
PUT
Zillow
Z
$8.07B
| $1.29M | ﹤0.01% |
41,000
-16,400
| -29% | -$630K |
|
2208
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $1.29M | ﹤0.01% |
6,963
-60,524
| -90% | -$10.5M |
|
2209
CALL
CoreCivic
CXW
$3.36B
| $1.29M | ﹤0.01% |
42,400
+17,200
| +68% | +$390K |
|
2210
iShares US Healthcare ETF
IYH
$3.86B
| $1.29M | ﹤0.01% |
+19,196
| New | +$1.2M |
|
2211
CALL
Scotiabank
BNS
$107B
| $1.29M | ﹤0.01% |
14,800
+1,000
| +7% | +$78.7K |
|
2212
JPMorgan Equity Premium Income ETF
JEPI
$46.1B
| $1.29M | ﹤0.01% |
+22,754
| New | +$1.29M |
|
2213
PUT
ATI
ATI
$28.2B
| $1.28M | ﹤0.01% |
6,500
-11,700
| -64% | -$1.98M |
|
2214
PUT
CME Group
CME
$98.9B
| $1.28M | ﹤0.01% |
5,800
-5,900
| -50% | -$1.63M |
|
2215
PUT
McCormick & Company Non-Voting
MKC
$14.9B
| $1.28M | ﹤0.01% |
25,400
-17,900
| -41% | -$878K |
|
2216
CALL
Mettler-Toledo International
MTD
$28B
| $1.28M | ﹤0.01% |
+1,000
| New | +$1.21M |
|
2217
CALL
Moderna
MRNA
$57.9B
| $1.27M | ﹤0.01% |
18,200
-60,500
| -77% | -$3.13M |
|
|
KMTS
2218
Kestra Medical Technologies
KMTS
$1.58B
| $1.27M | ﹤0.01% |
49,977
+18,077
| +57% | +$378K |
|
2219
CALL
UiPath
PATH
$8.49B
| $1.26M | ﹤0.01% |
116,300
-130,900
| -53% | -$1.4M |
|
2220
PUT
Cognizant
CTSH
$27.9B
| $1.26M | ﹤0.01% |
32,600
-13,900
| -30% | -$732K |
|
2221
CALL
Southern Company
SO
$102B
| $1.25M | ﹤0.01% |
13,100
+6,800
| +108% | +$640K |
|
2222
PUT
Huntington Bancshares
HBAN
$34.4B
| $1.25M | ﹤0.01% |
70,700
+31,200
| +79% | +$515K |
|
2223
Healthcare Services Group
HCSG
$1.56B
| $1.25M | ﹤0.01% |
50,959
+22,958
| +82% | +$485K |
|
2224
Hyliion Holdings
HYLN
$595M
| $1.25M | ﹤0.01% |
240,198
-57,370
| -19% | -$239K |
|
2225
PUT
British American Tobacco
BTI
$121B
| $1.25M | ﹤0.01% |
20,200
-30,800
| -60% | -$1.86M |
|
Similar funds
Paul Tudor Jones's Q2 2026 Portfolio in Review
As of Q2 2026, Paul Tudor Jones held 4,450 positions worth $71.9B, up 33% from $53.9B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Paul Tudor Jones deployed $8.74B of net new capital in Q2 2026, opening 936 new positions and adding to 1,167 existing holdings. Its largest new stake was Oracle: 1,262,004 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $508M trimmed.
- Paul Tudor Jones's largest Q2 2026 buy was Oracle: 1,262,004 shares worth $185M.
- Paul Tudor Jones added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $1.03B increase.
- Paul Tudor Jones's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $508M.
- Paul Tudor Jones fully exited Sealed Air in Q2 2026, selling an estimated $179M.
- Paul Tudor Jones's ten largest holdings make up 35% of its $71.9B portfolio in Q2 2026.
- Paul Tudor Jones opened 936 new positions and closed 993 in Q2 2026.
- Paul Tudor Jones's portfolio value rose 33% quarter-over-quarter to $71.9B.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.